Skip to main content

DNAStar Extends Lasergene License to Memorial Sloan-Kettering

NEW YORK (GenomeWeb News) – DNAStar has extended its site license agreement with Memorial Sloan-Kettering Cancer Center for the Lasergene sequence analysis software, DNAStar said today.
 
Under the three-year agreement, the software will be available to all of the researchers at MSKCC’s New York City location.
 
The cancer center first licensed the software, which can be used for assembly and analysis applications for conventional and next-generation sequencing programs, in 2000.
 
Financial terms of the agreement were not released.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.